David Calfee, MD, MS, FIDSA
he/him/his
Professor of Internal Medicine (Infectious Diseases)Cards
About
Research
Publications
2026
The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME Trial
Pogue J, Rybak M, Abdul-Mutakabbir J, Stamper K, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu C, Daikos G, Dhar S, Durante-Mangoni E, Gikas A, Kotanidou A, Paul M, Roilides E, Samarkos M, Sims M, Tancheva D, Tsiodras S, Kett D, Patel G, Calfee D, Leibovici L, Power L, Munoz-Price S, Susick L, Latack K, Chiou C, Divine G, Ghazyaran V, Narayanan N, Kaye K. The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME Trial. Clinical Microbiology And Infection 2026 PMID: 42250757, DOI: 10.1016/j.cmi.2026.05.046.Peer-Reviewed Original ResearchPopulation pharmacokinetics of polymyxin B: an individual participant data meta-analysis
Matcha S, Rao G, Hanafin P, Liu X, Yu Z, Zhang J, Qiu H, Cheng Y, Zavascki A, Sandri A, Kwa A, Scheetz M, Kubin C, Shah J, Cherng B, Yin M, Wang J, Wang L, Calfee D, Bolon M, Purcell A, Nation R, Pogue J, Kaye K, Li J. Population pharmacokinetics of polymyxin B: an individual participant data meta-analysis. Clinical Microbiology And Infection 2026 PMID: 42229684, DOI: 10.1016/j.cmi.2026.05.036.Peer-Reviewed Original Research
2025
Hospital-onset methicillin-resistant Staphylococcus aureus bloodstream infections within tertiary and community hospitals and implications for prevention
Singh H, Ross B, Hannah J, Ting S, Teasdale C, Wang X, Quinn M, Calfee D, Simon M, Torres H, Acker K, Horowitz H, Wang T, Gunawardhana N, Golderg R, Salazar Y, Prasad N, Jagnatnarain N, Johnson C, Kuang D, Gouveia A, Furuya Y, Westervelt K, Saiman L. Hospital-onset methicillin-resistant Staphylococcus aureus bloodstream infections within tertiary and community hospitals and implications for prevention. Infection Control And Hospital Epidemiology 2025, 47: 236-243. PMID: 41363446, PMCID: PMC12932923, DOI: 10.1017/ice.2025.10370.Peer-Reviewed Original ResearchInvestigation and control of an outbreak of methicillin-susceptible Staphylococcus aureus skin and soft tissue infections in a neonatal intensive care unit.
Rivera-Valenzuela G, Senaldi L, Tiwari P, Yap V, Cannon J, Saiman L, Calfee D, Marino J, Rólon R, Mitchell K, Rowlinson M, Haas W, Sankaranarayanan K, Westblade L, Acker K. Investigation and control of an outbreak of methicillin-susceptible Staphylococcus aureus skin and soft tissue infections in a neonatal intensive care unit. Infection Control And Hospital Epidemiology 2025, 47: 139-144. PMID: 41243561, DOI: 10.1017/ice.2025.10303.Peer-Reviewed Original ResearchThe Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of People With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens
Huralska M, Pogue J, Rybak M, Abdul-Mutakabbir J, Stamper K, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu C, Daikos G, Dhar S, Durante-Mangoni E, Gikas A, Kotanidou A, Paul M, Roilides E, Samarkos M, Sims M, Tancheva D, Tsiodras S, Kett D, Patel G, Calfee D, Leibovici L, Power L, Munoz-Price S, Shaikh H, Susick L, Latack K, Chiou C, Divine G, Ghazyaran V, Kaye K. The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of People With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens. Clinical Infectious Diseases 2025, 82: 391-398. PMID: 40682801, PMCID: PMC13016684, DOI: 10.1093/cid/ciaf398.Peer-Reviewed Original ResearchPopulation Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity
Hanafin P, Mahadevan R, Rao G, Zavascki A, Sandri A, Kwa A, Scheetz M, Kubin C, Shah J, Cherng B, Yin M, Wang J, Wang L, Calfee D, Bolon M, Purcell A, Nation R, Pogue J, Li J, Kaye K. Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity. Clinical Pharmacology & Therapeutics 2025, 118: 841-852. PMID: 40524377, PMCID: PMC12353974, DOI: 10.1002/cpt.3729.Peer-Reviewed Original ResearchA discrete choice experiment to evaluate healthcare personnel preferences regarding risk-tailored policies for contact precautions for patients with methicillin-resistant Staphylococcus aureus
O’Hara L, Calfee D, Snyder G, Martin E, Angelino N, O’Hara N, Harris A. A discrete choice experiment to evaluate healthcare personnel preferences regarding risk-tailored policies for contact precautions for patients with methicillin-resistant Staphylococcus aureus. Infection Control And Hospital Epidemiology 2025, 46: 710-715. PMID: 40376809, DOI: 10.1017/ice.2025.65.Peer-Reviewed Original Research
2024
Healthcare personnel opinions regarding the feasibility of a risk-tailored approach to contact precautions for methicillin-resistant Staphylococcus aureus in the acute care setting
O’Hara L, Harris A, Calfee D, Snyder G, Cottam J, O’Hara N, Martin E. Healthcare personnel opinions regarding the feasibility of a risk-tailored approach to contact precautions for methicillin-resistant Staphylococcus aureus in the acute care setting. Infection Control And Hospital Epidemiology 2024, 45: 900-902. PMID: 38646712, DOI: 10.1017/ice.2024.54.Peer-Reviewed Original ResearchPutting the “all” in “safe health care for all”
Calfee D. Putting the “all” in “safe health care for all”. Infection Control And Hospital Epidemiology 2024, 45: 420-421. PMID: 38482591, DOI: 10.1017/ice.2024.33.Peer-Reviewed Original ResearchHigh touch surface bioburden associated with the use of disinfectants with and without continuously active disinfection in ambulatory care settings
Torres H, Marino J, Simon M, Singh H, Westblade L, Calfee D. High touch surface bioburden associated with the use of disinfectants with and without continuously active disinfection in ambulatory care settings. Infection Control And Hospital Epidemiology 2024, 45: 790-792. PMID: 38374787, PMCID: PMC11102821, DOI: 10.1017/ice.2024.27.Peer-Reviewed Original Research